Literature DB >> 21964443

Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.

Surinder M Singh1, Aparna Sharma1, Arun K Upadhyay1, Anupam Singh1, Lalit C Garg1, Amulya K Panda2.   

Abstract

Inclusion bodies of recombinant human growth hormone (r-hGH) were isolated from Escherichia coli, enriched and solubilized in 100mM Tris buffer containing 6M n-propanol and 2M urea. Around 4 mg/ml of r-hGH from inclusion bodies were solubilized in 6M n-propanol-based buffer containing 2M urea. Existence of native-like secondary structure of r-hGH in 6M n-propanol solution was confirmed by CD and fluorescence spectra. Solubilized r-hGH was subsequently refolded by pulsatile dilution, purified to homogeneity and found to be functionally active. Tris buffer containing 6M n-propanol and 2M urea also effectively solubilized a number of proteins expressed as inclusion bodies in E. coli. Mild solubilization of inclusion body proteins, chaotropic effect of n-propanol at high concentration and kosmotropic effect at lower concentration helped in improved refolding of the solubilized protein. Around 40% of the r-hGH in the form of inclusion body aggregates was refolded into bioactive form while using n-propanol as solubilization agent. Solubilization with 6M n-propanol solution thus can be a viable alternative for achieving high throughput recovery of bioactive protein from inclusion bodies of E. coli. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964443     DOI: 10.1016/j.pep.2011.09.004

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  21 in total

1.  Dynamic transcriptional response of Escherichia coli to inclusion body formation.

Authors:  Faraz Baig; Lawrence P Fernando; Mary Alice Salazar; Rhonda R Powell; Terri F Bruce; Sarah W Harcum
Journal:  Biotechnol Bioeng       Date:  2014-01-30       Impact factor: 4.530

2.  Solubilization and Refolding of Inclusion Body Proteins.

Authors:  Priyank Singhvi; Amulya K Panda
Journal:  Methods Mol Biol       Date:  2022

3.  Purification of an IgA Monoclonal Antibody Specific for the Acr Protein of Mycobacterium tuberculosis by Immunoaffinity Chromatography.

Authors:  Fátima Reyes; Oscar Otero; Frank Camacho; María Elena Sarmiento; Armando Acosta
Journal:  Malays J Med Sci       Date:  2013-10

4.  Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli.

Authors:  Arun K Upadhyay; Aruna Murmu; Anupam Singh; Amulya K Panda
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

5.  A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form.

Authors:  Xingmei Qi; Yifan Sun; Sidong Xiong
Journal:  Microb Cell Fact       Date:  2015-02-22       Impact factor: 5.328

Review 6.  Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.

Authors:  Anupam Singh; Vaibhav Upadhyay; Arun Kumar Upadhyay; Surinder Mohan Singh; Amulya Kumar Panda
Journal:  Microb Cell Fact       Date:  2015-03-25       Impact factor: 5.328

7.  At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization.

Authors:  Julian Ebner; Diana Humer; Robert Klausser; Viktor Rubus; Reinhard Pell; Oliver Spadiut; Julian Kopp
Journal:  Bioengineering (Basel)       Date:  2021-06-07

Review 8.  Inclusion bodies: not that bad….

Authors:  Ana Ramón; Mario Señorale-Pose; Mónica Marín
Journal:  Front Microbiol       Date:  2014-02-14       Impact factor: 5.640

9.  Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein.

Authors:  Arun K Upadhyay; Anupam Singh; K J Mukherjee; Amulya K Panda
Journal:  Front Microbiol       Date:  2014-09-15       Impact factor: 5.640

10.  Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice.

Authors:  Nahid Mehri; Abbas Jamshidizad; Zahra Ghanei; Ali-Asghar Karkhane; Mehdi Shamsara
Journal:  Mol Biotechnol       Date:  2021-07-16       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.